Net Cash Provided by (Used in) Financing Activities in USD of Regen BioPharma Inc from 2013 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Regen BioPharma Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2013 to Q4 2024.
- Regen BioPharma Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Dec 2024 was $65.8K, a 60.3% decline year-over-year.
- Regen BioPharma Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $631K, a 159% increase from 2023.
- Regen BioPharma Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $244K.
- Regen BioPharma Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$94K, a 107% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)